《2013 ESMO临床实践指南：成人急性髓性白血病的诊断、治疗与随访》  内容预览
    Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    制定者：欧洲肿瘤内科学会（ESMO,European Society for Medical Oncology）

    出处：  Ann Oncol. 2013 Aug 22.

    该指南为欧洲肿瘤内科学会2013年版的成人急性髓性白血病诊断、治疗与随访指南，指南介绍了成人急性髓性白血病的病因与流行病学、诊断与分子生物学、风险评估与诊断因素、治疗、个体化医疗以及疗效评估与预后。

    指南推荐要点：

    Diagnostic work-up of AML must in include morphology of pe**heral blood and bone marrow, cytogenetics and molecular genetics assessed before start of therapy

    HLA-typing of patient and family members to plan for allogeneic stem cell transplantation where indicated

    AML should only be treated in specialised and experienced centres offering a multidisciplinary approach, and the possibility of clinical trials

    AML therapy with curative intent includes induction chemotherapy （incorporating an anthracycline and cytarabine）， consolidation which in intermediate to high-risk patients may incorporate allogeneic stem cell transplantation

    APL needs a specific therapy approach. ATRA must be started whenever in a case of leukaemia the differential diagnosis of APL is considered, and combined with anthracycline-based chemotherapy once the diagnosis of APL is confirmed

ESMO急性髓性白血病诊治随访指南:
http://ziyuan.iiyi.com/source/down/2321399.html